Patents by Inventor Dean P. Taylor

Dean P. Taylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutically active compounds and methods of use thereof
    Patent number: 7199113
    Abstract: The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treatment or prophylaxis of undesired thrombosis.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: April 3, 2007
    Inventors: Jin-An Jiao, Lawrence K. Luepschen, Esperanza Nieves, Hing C. Wong, Dean P. Taylor
  • Tissue factor antagonists and methods of use thereof
    Patent number: 6849617
    Abstract: The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treating or prophylaxis of undesired thrombosis.
    Type: Grant
    Filed: May 23, 2003
    Date of Patent: February 1, 2005
    Assignee: Sunol Molecular Corporation
    Inventors: Jin-An Jiao, Lawrence K. Luepschen, Esperanza L. Nieves, Hing C. Wong, Dean P. Taylor
  • Pharmaceutically active compounds and methods of use thereof
    Patent number: 6828312
    Abstract: The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treatment or prophylaxis of undesired thrombosis.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: December 7, 2004
    Assignee: Sunol Molecular Corporation
    Inventors: Jin-An Jiao, Lawrence K. Luepschen, Esperanza Nieves, Hing C. Wong, Dean P. Taylor
  • Tissue factor antagonists and methods of use thereof
    Publication number: 20030207895
    Abstract: The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treating or prophylaxis of undesired thrombosis.
    Type: Application
    Filed: May 23, 2003
    Publication date: November 6, 2003
    Applicant: Sunol Molecular Corporation
    Inventors: Jin-An Jiao, Lawrence K. Luepschen, Esperanza L. Nieves, Hing C. Wong, Dean P. Taylor
  • Tissue factor antagonists and methods of use thereof
    Patent number: 6608066
    Abstract: The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treating or prophylaxis of undesired thrombosis.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: August 19, 2003
    Assignee: Sunol Molecular Corporation
    Inventors: Jin-An Jiao, Lawrence K. Luepschen, Esperanza L. Nieves, Hing C. Wong, Dean P. Taylor
  • PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20020065327
    Abstract: The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treatment or prophylaxis of undesired thrombosis.
    Type: Application
    Filed: September 24, 1999
    Publication date: May 30, 2002
    Inventors: JIN-AN JIAO, LAWRENCE K. LUEPSCHEN, ESPERANZA L. NIEVES, HING C. WONG, DEAN P. TAYLOR
  • Protein protease inhibitors from streptomyces
    Patent number: 5498529
    Abstract: This invention relates to a process for producing a heterologous polypeptide in Streptomyces which involves transforming a Streptomyces organism with a recombinant DNA molecule comprising an LEP-10 of LTl sequence selected from the group consisting of a sequence encoding a gene expression unit, a promoter sequence or an export control encoding sequence each operatively linked to a heterologous coding sequence and then culturing the transformed Streptomyces such that the heterologous polypeptide is expressed.
    Type: Grant
    Filed: December 3, 1993
    Date of Patent: March 12, 1996
    Assignee: SmithKline Beckman Corporation
    Inventors: Thomas R. Berka, James A. Fornwald, Joselina G. Gorniak, Martin Rosenberg, James E. Strickler, Dean P. Taylor
  • Protein protease inhibitors from streptomyces
    Patent number: 5279939
    Abstract: This invention relates to novel protein protease inhibitors as well as DNAs encoding same and vectors and transformed host cells useful for the recombinant production of the inhibitors.
    Type: Grant
    Filed: June 3, 1992
    Date of Patent: January 18, 1994
    Assignee: SmithKline Beecham Corporation
    Inventors: Thomas R. Berka, James A. Fornwald, Joselina G. Gorniak, Martin Rosenberg, James E. Strickler, Dean P. Taylor
  • Plasmids from nocardia
    Patent number: 4791064
    Abstract: A plasmid naturally present in N. orientalis can be used as a vector for cloning or expression in Actinomycetales and to derive other vectors.
    Type: Grant
    Filed: June 12, 1985
    Date of Patent: December 13, 1988
    Assignee: SmithKline Beckman Corporation
    Inventors: Louis R. Fare, Yong K. Oh, Dean P. Taylor, Jenifer B. Widger
  • Cosmid cloning vectors
    Patent number: 4476227
    Abstract: Small cosmid cloning vectors having two antibiotic resistance markers, selected from chloramphemicol resistance, streptomycin and spectinomycin resistance and tetracycline resistance markers, at least one having a unique restriction site.
    Type: Grant
    Filed: October 6, 1982
    Date of Patent: October 9, 1984
    Assignee: Smithkline Beckman Corporation
    Inventor: Dean P. Taylor